CN Patent

CN111542527A — 芦卡帕利樟脑磺酸盐的新晶型和制备方法及其用途

Assigned to Shanghai Begreat Pharmatech · Expires 2020-08-14 · 6y expired

What this patent protects

本发明公开了芦卡帕利樟脑磺酸盐的新多晶型D及其制备方法和药用用途。与现有晶型相比，新晶型在溶解度、稳定性和制备工艺方面具有明显优势。

USPTO Abstract

本发明公开了芦卡帕利樟脑磺酸盐的新多晶型D及其制备方法和药用用途。与现有晶型相比，新晶型在溶解度、稳定性和制备工艺方面具有明显优势。

Drugs covered by this patent

rucaparib-camsylate (RUCAPARIB CAMSYLATE)

Patent Metadata

Patent number: CN111542527A
Jurisdiction: CN
Classification: —
Expires: 2020-08-14
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Begreat Pharmatech
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.